- Home
- COOT vs ATHA Comparison
COOT vs ATHA Comparison
Compare COOT & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOT
- ATHA
- Stock Information
- Founded
- COOT 2020
- ATHA 2011
- Country
- COOT Australia
- ATHA United States
- Employees
- COOT N/A
- ATHA N/A
- Industry
- COOT
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- COOT
- ATHA Health Care
- Exchange
- COOT NYSE
- ATHA Nasdaq
- Market Cap
- COOT 20.2M
- ATHA 10.6M
- IPO Year
- COOT N/A
- ATHA 2020
- Fundamental
- Price
- COOT $0.81
- ATHA $0.31
- Analyst Decision
- COOT
- ATHA Buy
- Analyst Count
- COOT 0
- ATHA 4
- Target Price
- COOT N/A
- ATHA $11.25
- AVG Volume (30 Days)
- COOT 29.4K
- ATHA 573.2K
- Earning Date
- COOT 01-01-0001
- ATHA 05-09-2025
- Dividend Yield
- COOT N/A
- ATHA N/A
- EPS Growth
- COOT N/A
- ATHA N/A
- EPS
- COOT N/A
- ATHA N/A
- Revenue
- COOT $21,517,422.00
- ATHA N/A
- Revenue This Year
- COOT N/A
- ATHA N/A
- Revenue Next Year
- COOT N/A
- ATHA N/A
- P/E Ratio
- COOT N/A
- ATHA N/A
- Revenue Growth
- COOT 16.10
- ATHA N/A
- 52 Week Low
- COOT $0.61
- ATHA $0.22
- 52 Week High
- COOT $1.69
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- COOT 51.17
- ATHA 61.74
- Support Level
- COOT $0.72
- ATHA $0.26
- Resistance Level
- COOT $0.77
- ATHA $0.30
- Average True Range (ATR)
- COOT 0.05
- ATHA 0.02
- MACD
- COOT 0.02
- ATHA 0.00
- Stochastic Oscillator
- COOT 59.69
- ATHA 83.45
About COOT AUSTRALIAN OILSEEDS HOLDINGS LTD
Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently. Company's edible oil sales comprise of two segments: sales of bulk oils to wholesalers who use it as food ingredients or white labeling; sales of packaged oils as the company's own branding to supermarket channels. Sales of protein meals are bulk sales and mainly distributed to local farmers and feedlots as protein supplements.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.